Medicines A–Z
M
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Medroxyprogesterone acetate (Sayana Press) 104mg in 0.65ml SC injection | Suitable for self-injection in patients who have had appropriate training |
|
|
Medroxyprogesterone acetate tablets | Provera and Climanor |
|
 |
Medroxyprogesterone injection 150mg/1ml | Umbrella service only |
|
|
Mefenamic acid capsules | For dysmenorrhoea |
|
|
Mefenamic acid tablets | For dysmenorrhoea |
|
 |
Megestrol acetate tablets | ||
|
Melatonin 2mg M/R tablets (Circadin®) | ||
|
Melatonin 2mg M/R tablets (Circadin®) | REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults |
|
|
Melatonin 3mg tablets | REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults |
|
|
Melatonin capsules | Unlicensed |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
